Keywords: roche, sell, fujisawa, protopic, japan-headquartered, swiss, drug
Roche to sell Fujisawa's Protopic
Article | 09 February 2004
Japan-headquartered Fujisawa and Swiss drug major Roche have entered into an exclusive agreement regarding the former's Protopic (tacrolimus), a topical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
